Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Seibyl

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Advances in Neurology|November 22, 2002
Single-photon emission tomography and dopamine transporter imaging in Parkinson's diseaseKenneth Marek, Danna Jennings, John Seibyl
Annals of Neurology|April 1, 2003
Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studiesKenneth Marek, Danna Jennings, John Seibyl
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|September 26, 2002
Medical imaging in neurological disordersAlan Waxman, Harry Chugani, John Seibyl
Neurology|September 25, 2003
Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopaKenneth Marek, Danna Jennings, John Seibyl
Expert Review of Neurotherapeutics|March 11, 2015
The role of positron emission tomography imaging in understanding Alzheimer's diseaseHenryk Barthel, John Seibyl, Osama Sabri
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2017
Yes we can analyse amyloid images - Now What?Henryk Barthel, John Seibyl, Osama Sabri
Seminars in Nuclear Medicine|August 3, 2010
The role of the core imaging laboratory in multicenter trialsJohn Seibyl, Kenneth Marek, I George Zubal
Journal of Neurology|October 27, 2004
Neuroimaging trials of Parkinson's disease progressionJohn Seibyl, Danna Jennings, Rowena Tabamo, et al.
Annals of Neurology|January 8, 2009
Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progressionKenneth Marek, Danna Jennings, Gilles Tamagnan, et al.
Clinical and Translational Imaging|March 6, 2015
Beta-amyloid imaging with florbetabenOsama Sabri, John Seibyl, Christopher Rowe, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Advances in Neurology|November 22, 2002
Single-photon emission tomography and dopamine transporter imaging in Parkinson's diseaseKenneth Marek, Danna Jennings, John Seibyl
Annals of Neurology|April 1, 2003
Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studiesKenneth Marek, Danna Jennings, John Seibyl
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|September 26, 2002
Medical imaging in neurological disordersAlan Waxman, Harry Chugani, John Seibyl
Neurology|September 25, 2003
Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopaKenneth Marek, Danna Jennings, John Seibyl
Expert Review of Neurotherapeutics|March 11, 2015
The role of positron emission tomography imaging in understanding Alzheimer's diseaseHenryk Barthel, John Seibyl, Osama Sabri
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2017
Yes we can analyse amyloid images - Now What?Henryk Barthel, John Seibyl, Osama Sabri
Seminars in Nuclear Medicine|August 3, 2010
The role of the core imaging laboratory in multicenter trialsJohn Seibyl, Kenneth Marek, I George Zubal
Journal of Neurology|October 27, 2004
Neuroimaging trials of Parkinson's disease progressionJohn Seibyl, Danna Jennings, Rowena Tabamo, et al.
Annals of Neurology|January 8, 2009
Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progressionKenneth Marek, Danna Jennings, Gilles Tamagnan, et al.
Clinical and Translational Imaging|March 6, 2015
Beta-amyloid imaging with florbetabenOsama Sabri, John Seibyl, Christopher Rowe, et al.
Pageof 11